10x Genomics
IPOPowering researchers' insights with innovative single cell, spatial biology, & in situ tools
Public · Pleasanton, United States · Founded 2012 · $160.5M raised
- Headquarters
- Pleasanton, California
- Employees
- 1001–5000
- Founded
- 2012
- Business Model
- B2B
- Website
- 10xgenomics.com
- Total Funding
- $160.5M
- Last Round
- $50.0M Series DApr 2018
- Rounds
- 3
- Type
- Public
About
10x Genomics delivers powerful, reliable instruments, reagents, and software for single-cell, spatial, and in situ genomic analysis, enabling researchers to make discoveries across oncology, immunology, and neuroscience. Cited in more than 10,000 research papers, the company has placed 4,600+ instruments at top global institutions and holds 1,750+ patents.
Summary
10x Genomics is a Biotech company based in Pleasanton, United States, founded in 2012. It has raised $160.5M in total across 3 rounds, most recently a $50.0M Series D round in Apr 2018.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2018
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...